secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2023-11-29T23:59:59+00:00
Accession:  0001493152-23-043098
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics receives Nasdaq minimum bid price deficiency notice
---------------------------------------------------------------------------

- Nasdaq notified PTIX on Nov 21, 2023 that common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 calendar days, until May 19, 2024, to regain compliance with bid price requirement.
- To regain compliance, closing bid price must be at least $1.00 for ten consecutive business days.
- If not cured by May 19, 2024, PTIX may be eligible for an additional 180-day period if it meets other listing standards.
- Stock continues trading on Nasdaq Capital Market under symbol PTIX; no immediate delisting effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315223043098/0001493152-23-043098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315223043098/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer